5-hydroxytryptophan has been researched along with Scleroderma, Systemic in 4 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rush, PJ | 1 |
| Bell, MJ | 1 |
| Fam, AG | 1 |
| Fine, RM | 1 |
| Sternberg, EM | 1 |
| Van Woert, MH | 1 |
| Young, SN | 1 |
| Magnussen, I | 1 |
| Baker, H | 1 |
| Gauthier, S | 1 |
| Osterland, CK | 1 |
| Chamson, A | 1 |
| Périer, C | 1 |
| Frey, J | 1 |
1 trial available for 5-hydroxytryptophan and Scleroderma, Systemic
| Article | Year |
|---|---|
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Com | 1980 |
3 other studies available for 5-hydroxytryptophan and Scleroderma, Systemic
| Article | Year |
|---|---|
Toxic oil syndrome (Spanish oil disease) and chemically induced scleroderma-like conditions.
Topics: 5-Hydroxytryptophan; Bleomycin; Brassica; Carbidopa; Humans; Oils; Pentazocine; Plastics; Scleroderm | 1984 |
Drug-related scleroderma-like illness. The Fine page.
Topics: 5-Hydroxytryptophan; Carbidopa; Drug Combinations; Humans; Kynurenine; Scleroderma, Systemic | 1981 |
[Sclerodermiform and poikilodermic syndrome during treatment with carbidopa and 5-hydroxytryptophan. Culture of fibroblasts with biochemical analysis of collagen metabolism].
Topics: 5-Hydroxytryptophan; Carbidopa; Cells, Cultured; Collagen; Drug Therapy, Combination; Fibroblasts; H | 1986 |